Abstract
It is now clear that are two histological types (Type-1 and Type-2) of autoimmune pancreatitis (AIP). The histological pattern of Type-1 AIP, or traditional AIP, is called lymphoplasmacytic sclerosing pancreatitis (LPSP). The histological pattern of Type-2 AIP is characterized by neutrophilic infiltration in the epithelium of the pancreatic duct. In general, Type-2 AIP patients are younger, may not have a male preponderance, and rarely show elevation of serum IgG4 compared with Type-1 AIP patients. Unlike Type-1 AIP patients, Type-2 AIP patients rarely have associated sclerosing diseases, but they are more likely to have acute pancreatitis and ulcerative colitis. Although Type-2 AIP is sometimes observed in the USA and Europe, most AIP cases in Japan and Korea are Type-1. The international consensus diagnostic criteria for AIP comprise 5 cardinal features, and combinations of one or more of these features provide the basis for diagnoses of both Type-1 and Type-2 AIP. Due to the fact that steroid therapy is clinically, morphologically, and serologically effective in AIP patients, it is the standard therapy for AIP. The indications for steroid therapy in AIP include symptoms such as obstructive jaundice and the presence of symptomatic extrapancreatic lesions. Oral prednisolone (0.6 mg/kg/day) is administered for 2–4 weeks and gradually tapered to a maintenance dose of 2.5–5 mg/day over a period of 2–3 months. Maintenance therapy by low-dose prednisolone is usually performed for 1–3 years to prevent relapse of AIP.
Highlights
Autoimmune pancreatitis (AIP) is a rare disease that has recently emerged as a peculiar type of pancreatitis with a presumed autoimmune etiology
In 1995, Yoshida et al first proposed the concept of AIP, and they summarized the clinical features as follows: increased serum γ-globulin or IgG levels and the presence of autoantibodies; diffuse irregular narrowing of the main pancreatic duct and enlargement of the pancreas; occasional association with stenosis of the lower bile duct and other autoimmune diseases; mild symptoms, usually without acute attacks of pancreatitis; effectiveness of steroid therapy; and histological finding of lymphoplasmacytic sclerosing pancreatitis (LPSP) (Yoshida et al, 1995)
Histological examination of pancreases resected on suspicion of pancreatic cancer from patients with mass-forming chronic pancreatitis, American and European pathologists have described another unique histological pattern, called idiopathic duct-centric pancreatitis (IDCP) (Notohara et al, 2003), or AIP with granulocytic epithelial lesion (GEL) (Zamboni et al, 2004)
Summary
Terumi Kamisawa 1*, Taku Tabata 1, Seiichi Hara 1, Sawako Kuruma, Kazuro Chiba, Atsushi Kanno 2, Atsushi Masamune 2 and Tooru Shimosegawa 2. Edited by: Atsushi Masamune, Tohoku University Graduate School of Medicine, Japan. It is clear that are two histological types (Type-1 and Type-2) of autoimmune pancreatitis (AIP). The histological pattern of Type-1 AIP, or traditional AIP, is called lymphoplasmacytic sclerosing pancreatitis (LPSP). The histological pattern of Type-2 AIP is characterized by neutrophilic infiltration in the epithelium of the pancreatic duct. Type-2 AIP patients are younger, may not have a male preponderance, and rarely show elevation of serum IgG4 compared with Type-1 AIP patients. Unlike Type-1 AIP patients, Type-2 AIP patients rarely have associated sclerosing diseases, but they are more likely to have acute pancreatitis and ulcerative colitis. Maintenance therapy by low-dose prednisolone is usually performed for 1–3 years to prevent relapse of AIP
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
